Reply to Rational drug repositioning by medical genetics

Nature Biotechnology

Volumn 31, Issue 12, 2013, Pages 1082-

  Sanseau, Philippe ^a   Agarwal, Pankaj ^a   Barnes, Michael R ^b   Pastinen, Tomi ^c   Richards, J Brent ^d   Cardon, Lon R ^e   Mooser, Vincent ^f  

^a GLAXOSMITHKLINE   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e GLAXOSMITHKLINE   (United States)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN 1 RECEPTOR;

ALLELE; B LYMPHOBLAST; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LETTER; OSTEOBLAST; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

DRUG THERAPY; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INDIVIDUALIZED MEDICINE;

EID: 84890111836     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2769     Document Type: Letter

References (9)

1. Wang, Z-Y. & Zhang, H-Y. Nat. Biotechnol. 31, 1080- 1082 (2013
2. Sanseau, P. et al. Nat. Biotechnol. 30, 317-320 (2012
3. Collins, F.S. Sci. Transl. Med. 3, 90cm17 (2011
4. Richards, J.B. et al. Nat. Rev. Genet. 13, 576-588 (2012
5. Ge, B. et al. Nat. Genet. 41, 1216-1222 (2009
6. Bonnefond, A. et al. Nat. Genet. 44, 297-301 (2012
7. Bouatia-Naji, N. et al. Nat. Genet. 41, 89-94 (2009
8. The ENCODE Project Consortium. Nature 489, 57-74 (2012
9. Xue, Y. et al. Am. J. Hum. Genet. 91, 1022-1032 (2012